Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Flexion Therapeutics Inc. FLXN

Healthcare Drug Manufacturers - Major
Flexion Therapeutics Inc is a United States-based specialty pharmaceutical company. The company focuses on the development and commercialization of novel, local therapies. The company specializes in the treatment of patients with musculoskeletal conditions beginning with osteoarthritis. The products offered by company are zilretta which is used for enhancing the clinical effect of intra... see more

Recent & Breaking News (NDAQ:FLXN)

Flexion Therapeutics Announces Positive Topline Results From Phase 2a Pharmacokinetic Trial With Lead Compound FX006

GlobeNewswire June 17, 2014

Flexion Therapeutics Announces Changes to Board of Directors

GlobeNewswire June 12, 2014

Flexion Therapeutics to Present at Wells Fargo Securities Research, Economics & Strategy 2014 Healthcare Conference

GlobeNewswire June 11, 2014

Flexion Therapeutics to Present at the 2014 Jefferies Healthcare Conference

GlobeNewswire May 27, 2014

Flexion Therapeutics Reports First-Quarter 2014 Financial Results

GlobeNewswire May 8, 2014

Flexion Therapeutics to Report First Quarter 2014 Financial Results on May 8, 2014

GlobeNewswire May 1, 2014

Flexion Therapeutics Initiates a Phase 2b Confirmatory Dose-Ranging Trial With Lead Compound FX006

GlobeNewswire April 30, 2014

Flexion Therapeutics to Present at the 13th Annual Needham Healthcare Conference

GlobeNewswire April 2, 2014

Flexion Reports Year-End 2013 Financial Results

GlobeNewswire March 27, 2014

Flexion Therapeutics to Report Year-End 2013 Earning Results on March 27, 2014

GlobeNewswire March 20, 2014

Flexion Therapeutics to Present at the 34th Annual Cowen Health Care Conference

GlobeNewswire February 26, 2014

Flexion Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewswire February 18, 2014